InterMune (ITMN) Higher Following INFORM-1 Trial Data
Tweet Send to a Friend
InterMune, Inc. (Nasdaq: ITMN) is 7% higher today after announcing, with Pharmasset, Inc. (Nasdaq: VRUS) and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


